Exact Mass: 460.1502016

Exact Mass Matches: 460.1502016

Found 144 metabolites which its exact mass value is equals to given mass value 460.1502016, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Paeonolide

1-[4-methoxy-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]phenyl]ethanone

C20H28O12 (460.1581)


Paeonolide is a glycoside. Paeonolide is a plant glycoside that contains a non-reducing end α-l-arabinopyranoside and is found in the roots of the widespread plant genus Paeonia[1]. Paeonolide is a plant glycoside that contains a non-reducing end α-l-arabinopyranoside and is found in the roots of the widespread plant genus Paeonia[1].

   

Oxytetracycline

(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide

C22H24N2O9 (460.1482)


Oxytetracycline is a tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions. [PubChem]Oxytetracycline inhibits cell growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. The binding is reversible in nature. Oxytetracycline is lipophilic and can easily pass through the cell membrane or passively diffuses through porin channels in the bacterial membrane. Oxytetracycline is a clinically used broad-spectrum antibacterial antibiotic. It is approved by FDA for use in fish and animal feeds. Oxytetracycline is known as a broad-spectrum antibiotic due to its activity against such a wide range of infections. It was the second of the tetracyclines to be discovered. Oxytetracycline, like other tetracyclines, is used to treat many infections common and rare. Its better absorption profile makes it preferable to tetracycline for moderately severe acne, but alternatives sould be sought if no improvement occurs by 3 months G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines Clinically used broad-spectrum antibacterial antibiotic. Approved by FDA for use in fish and animal feeds S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Oxytetracycline is an antibiotic belonging to the tetracycline class. Oxytetracycline potent inhibits Gram-negative and Gram-positive bacteria. Oxytetracycline is a protein synthesis inhibitor and prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline also possesses anti-HSV-1 activity[1][2][3].

   

11a-Hydroxytetracycline

(4S,4aS,5aR,6S,11aS,12aR)-4-(dimethylamino)-3,6,10,11a,12a-pentahydroxy-6-methyl-1,11,12-trioxo-1,4,4a,5,5a,6,11,11a,12,12a-decahydrotetracene-2-carboxamide

C22H24N2O9 (460.1482)


A member of the class of tetracyclines obtained by selective hydroxylation at position 11a of tetracycline.

   

Methyl salicylate O-[rhamnosyl-(1->6)-glucoside]

Methyl 2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzoic acid

C20H28O12 (460.1581)


Methyl salicylate O-[rhamnosyl-(1->6)-glucoside] is found in fruits. Methyl salicylate O-[rhamnosyl-(1->6)-glucoside] is a constituent of the fruit of purple passion fruit (Passiflora edulis). Constituent of the fruit of purple passion fruit (Passiflora edulis). Methyl salicylate O-[rhamnosyl-(1->6)-glucoside] is found in fruits.

   

Dexloxiglumide

4-{[(3,4-dichlorophenyl)(hydroxy)methylidene]amino}-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid

C21H30Cl2N2O5 (460.1532)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.

   

Oxyterracin

4-(Dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboximidate

C22H24N2O9 (460.1482)


   

Tert-butyl 4-[4-[(2-chloro-5-nitrobenzoyl)amino]phenyl]piperazine-1-carboxylate

N-(4-(4-Tert-butoxycarbonylpiperazin-1-yl)phenyl)-(2-chloro-5-nitrophenyl)carboxamide

C22H25ClN4O5 (460.1513)


   

apiopeonoside

1-[2-[6-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-methoxyphenyl]ethanone

C20H28O12 (460.1581)


Apiopaeonoside is a natural product isolated from the root of Paeonia suffruticosa[1]. Apiopaeonoside is a natural product isolated from the root of Paeonia suffruticosa[1].

   

Apiopaeonoside

Apiopaeonoside

C20H28O12 (460.1581)


Apiopaeonoside is a natural product isolated from the root of Paeonia suffruticosa[1]. Apiopaeonoside is a natural product isolated from the root of Paeonia suffruticosa[1].

   
   

CHEMBL188737

CHEMBL188737

C27H24O7 (460.1522)


   

BE-24566B

BE-24566B

C27H24O7 (460.1522)


An organic heterohexacyclic compound that is 6,7,9,16-tetrahydro-14H-6,16-epoxyanthra[2,3-e]benzo[b]oxocin-14-one substituted by hydroxy groups at positions 3, 11, 13 and 15, methyl groups at positions 1 and 4 and geminal methyl groups at position 9 respectively. It is isolated from the fermentation broth of Streptomyces violaceusniger and exhibits moderate antibacterial activity.

   

Bequinostatin B

Bequinostatin B

C27H24O7 (460.1522)


   

Phenazostatin A

Phenazostatin A

C28H20N4O3 (460.1535)


   

Methyl 2-{[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy}benzoate

Methyl 2-{[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy}benzoate

C20H28O12 (460.1581)


   
   
   

13-chloro-3-O-beta-D-glucopyranosylsolstitialin

13-chloro-3-O-beta-D-glucopyranosylsolstitialin

C21H29ClO9 (460.15)


   

1,2,3,4-tetrahydroxy-2-methylbutane-4-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside

1,2,3,4-tetrahydroxy-2-methylbutane-4-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside

C20H28O12 (460.1581)


   

O-De-(3,4-dehydroxycinnamoyl)-Crenatoside

O-De-(3,4-dehydroxycinnamoyl)-Crenatoside

C20H28O12 (460.1581)


   

3,4-dimethoxyphenyl-1-O-beta-D-[6-O-[(3S)3-hydroxy-3-methyl-glutaryl]]-glucopyranoside

3,4-dimethoxyphenyl-1-O-beta-D-[6-O-[(3S)3-hydroxy-3-methyl-glutaryl]]-glucopyranoside

C20H28O12 (460.1581)


   

7-O-alpha-L-rhamnopyranosyl-(1?6)-O-beta-D-glucopyranoside methyl salicylate

7-O-alpha-L-rhamnopyranosyl-(1?6)-O-beta-D-glucopyranoside methyl salicylate

C20H28O12 (460.1581)


   

amarastelline A

amarastelline A

C28H20N4O3 (460.1535)


   

1,2-(beta-3,4-dihydroxylphenyl-alpha,beta-dioxoethanol)-O-alpha-L-rhamnopyranosyl-(1 6)-beta-D-glucopyranoside|suspensaside C

1,2-(beta-3,4-dihydroxylphenyl-alpha,beta-dioxoethanol)-O-alpha-L-rhamnopyranosyl-(1 6)-beta-D-glucopyranoside|suspensaside C

C20H28O12 (460.1581)


   

cryptamygin-C

cryptamygin-C

C20H28O12 (460.1581)


   

Benzyl glycoside,Me ester-3-O-beta-D-Glucopyranuronosyl-D-galactose

Benzyl glycoside,Me ester-3-O-beta-D-Glucopyranuronosyl-D-galactose

C20H28O12 (460.1581)


   

(Z)-4xi,,6xi,7xi,9xi-Tetraacetoxy-5xi-hydroxy-8-oxododeca-2-enoic acid

(Z)-4xi,,6xi,7xi,9xi-Tetraacetoxy-5xi-hydroxy-8-oxododeca-2-enoic acid

C20H28O12 (460.1581)


   
   

10-demethoxy-11-ethoxydaphylloside|asperulosidic acid ethyl ester|ethyl(1S,4aS,5S,7aS)-7-[(acetyloxy)methyl]-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a,-tetrahydro-5-hydroxycyclopenta[c]pyran-4-carboxylate

10-demethoxy-11-ethoxydaphylloside|asperulosidic acid ethyl ester|ethyl(1S,4aS,5S,7aS)-7-[(acetyloxy)methyl]-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a,-tetrahydro-5-hydroxycyclopenta[c]pyran-4-carboxylate

C20H28O12 (460.1581)


   
   

N-(2-Phenylethyl)indomethacin Amide

N-(2-Phenylethyl)indomethacin Amide

C27H25ClN2O3 (460.1554)


   

Oxytetracycline

Oxytetracycline

C22H24N2O9 (460.1482)


A tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic relative retention time with respect to 9-anthracene Carboxylic Acid is 0.486 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.490 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3610 EAWAG_UCHEM_ID 3610; CONFIDENCE standard compound Oxytetracycline is an antibiotic belonging to the tetracycline class. Oxytetracycline potent inhibits Gram-negative and Gram-positive bacteria. Oxytetracycline is a protein synthesis inhibitor and prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline also possesses anti-HSV-1 activity[1][2][3].

   

clindamycin hydrochloride

Clindamycin hydrochloride (Dalacin)

C18H34Cl2N2O5S (460.1565)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

   

C20H28O12_6-O-(Phenylacetyl)-alpha-D-glucopyranosyl alpha-D-glucopyranoside

NCGC00380161-01_C20H28O12_6-O-(Phenylacetyl)-alpha-D-glucopyranosyl alpha-D-glucopyranoside

C20H28O12 (460.1581)


   

C20H28O12_4-Acetyl-2-methoxyphenyl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside

NCGC00384614-01_C20H28O12_4-Acetyl-2-methoxyphenyl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside

C20H28O12 (460.1581)


   

methyl 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxybenzoate

methyl 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxybenzoate

C20H28O12 (460.1581)


   

methyl 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxybenzoate_major

methyl 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxybenzoate_major

C20H28O12 (460.1581)


   

methyl 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxybenzoate_60.3\\%

methyl 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxybenzoate_60.3\\%

C20H28O12 (460.1581)


   

Oxytetracycline_major

Oxytetracycline_major

C22H24N2O9 (460.1482)


   

Oxytetracycline_55.1\\%

Oxytetracycline_55.1\\%

C22H24N2O9 (460.1482)


   

Ala Cys His Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C17H28N6O5S2 (460.1563)


   

Ala Cys Met His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Ala His Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H28N6O5S2 (460.1563)


   

Ala His Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Ala Met Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Ala Met His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Ala His Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Ala Met His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Cys His Val

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Cys Val His

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Cys His Ala Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H28N6O5S2 (460.1563)


   

Cys His Cys Val

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C17H28N6O5S2 (460.1563)


   

Cys His Met Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C17H28N6O5S2 (460.1563)


   

Cys His Val Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Met Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Met His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Val Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Cys Val His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Asp Asp Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C17H24N4O11 (460.1442)


   

Asp Asp Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C17H24N4O11 (460.1442)


   

Asp Pro Asp Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]butanedioic acid

C17H24N4O11 (460.1442)


   

His Ala Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H28N6O5S2 (460.1563)


   

His Ala Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

His Cys Ala Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H28N6O5S2 (460.1563)


   

His Cys Cys Val

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C17H28N6O5S2 (460.1563)


   

His Cys Met Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C17H28N6O5S2 (460.1563)


   

His Cys Val Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

His Met Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

His Met Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanoic acid

C17H28N6O5S2 (460.1563)


   

His Val Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Met Ala Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Met Ala His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Met Cys Ala His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Met Cys His Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C17H28N6O5S2 (460.1563)


   

Met His Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Met His Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]propanoic acid

C17H28N6O5S2 (460.1563)


   

Pro Asp Asp Asp

(2S)-2-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid

C17H24N4O11 (460.1442)


   

Val Cys Cys His

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H28N6O5S2 (460.1563)


   

Val Cys His Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

Val His Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H28N6O5S2 (460.1563)


   

N-(2-phenylethyl)-Indomethacin amide

N-(2-phenylethyl)-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetamide

C27H25ClN2O3 (460.1554)


   

Methyl salicylate O-[rhamnosyl-(1->6)-glucoside]

methyl 2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzoate

C20H28O12 (460.1581)


   
   
   

PDK1 inhibitor AR-12

PDK1 inhibitor AR-12

C26H19F3N4O (460.1511)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

1-(PERFLUORO-N-HEXYL)DECANE

1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluorohexadecane

C16H21F13 (460.1436)


   

Dexloxiglumide

Dexloxiglumide

C21H30Cl2N2O5 (460.1532)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist[1]. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8)[2].

   
   

4-Epioxytetracycline

4-Epioxytetracycline

C22H24N2O9 (460.1482)


   

4-Nitrophenyl2-acetamido-2-deoxy-4,6-O-p-methoxybenzylidene-a-D-galactopyranoside

4-Nitrophenyl2-acetamido-2-deoxy-4,6-O-p-methoxybenzylidene-a-D-galactopyranoside

C22H24N2O9 (460.1482)


   

Loxiglumide

Loxiglumide

C21H30Cl2N2O5 (460.1532)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.

   

3,11,13,15-tetrahydroxy-1,6,9,9-tetramethyl-6,7,9,16-tetrahydro-14H-6,16-epoxyanthra[2,3-e]benzo[b]oxocin-14-one

3,11,13,15-tetrahydroxy-1,6,9,9-tetramethyl-6,7,9,16-tetrahydro-14H-6,16-epoxyanthra[2,3-e]benzo[b]oxocin-14-one

C27H24O7 (460.1522)


   

Terramycin

Terramycin

C22H24N2O9 (460.1482)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

   

N(alpha)-(L-gamma-glutamyl)-hercynyl-L-cysteine sulfoxide(1-)

N(alpha)-(L-gamma-glutamyl)-hercynyl-L-cysteine sulfoxide(1-)

C17H26N5O8S- (460.1502)


A peptide anion that is the conjugate base of N(alpha)-(L-gamma-glutamyl)-hercynyl-L-cysteine sulfoxide and major species at pH 7.3.

   

11a-Hydroxytetracycline-6,12-hemiketal

11a-Hydroxytetracycline-6,12-hemiketal

C22H24N2O9 (460.1482)


   

(3R,4R,8S,9S,11S,12S)-8-(dimethylamino)-3,4,5,12,15-pentahydroxy-1-methyl-7,13-dioxo-2-oxapentacyclo[9.8.0.03,12.04,9.014,19]nonadeca-5,14(19),15,17-tetraene-6-carboxamide

(3R,4R,8S,9S,11S,12S)-8-(dimethylamino)-3,4,5,12,15-pentahydroxy-1-methyl-7,13-dioxo-2-oxapentacyclo[9.8.0.03,12.04,9.014,19]nonadeca-5,14(19),15,17-tetraene-6-carboxamide

C22H24N2O9 (460.1482)


   

3-L-leucyl-AMP

3-L-leucyl-AMP

C16H25N6O8P (460.1471)


An L-leucine derivative that is the ester obtained by formal condensation of the carboxy group of L-leucine with the 3-hydroxy group of AMP.

   

3-L-isoleucyl-AMP

3-L-isoleucyl-AMP

C16H25N6O8P (460.1471)


An L-isoleucine derivative that is the ester obtained by formal condensation of the carboxy group of L-isoleucine with the 3-hydroxy group of AMP.

   

N-(4-ethoxyphenyl)-2-[5-oxo-1-phenyl-3-(2-pyridinylmethyl)-2-sulfanylidene-4-imidazolidinyl]acetamide

N-(4-ethoxyphenyl)-2-[5-oxo-1-phenyl-3-(2-pyridinylmethyl)-2-sulfanylidene-4-imidazolidinyl]acetamide

C25H24N4O3S (460.1569)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S,3S)-2-azanyl-3-methyl-pentanoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S,3S)-2-azanyl-3-methyl-pentanoate

C16H25N6O8P (460.1471)


   

L-isoleucyl-adenylate

L-isoleucyl-adenylate

C16H25N6O8P (460.1471)


   

N-[3-[4-(3-chloro-4-hydroxyanilino)-7-methoxyquinazolin-6-yl]oxypropyl]-N-(3-hydroxypropyl)formamide

N-[3-[4-(3-chloro-4-hydroxyanilino)-7-methoxyquinazolin-6-yl]oxypropyl]-N-(3-hydroxypropyl)formamide

C22H25ClN4O5 (460.1513)


   

Acetovanillone primeveroside

Acetovanillone primeveroside

C20H28O12 (460.1581)


   

(2S,4R)-N-[(1R)-2-chloro-1-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride

(2S,4R)-N-[(1R)-2-chloro-1-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride

C18H34Cl2N2O5S (460.1565)


   

oxytetracycline zwitterion

oxytetracycline zwitterion

C22H24N2O9 (460.1482)


A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the adjacent tertiary amino group of oxytetracycline; major species at pH 7.3.

   

11a-hydroxytetracycline zwitterion

11a-hydroxytetracycline zwitterion

C22H24N2O9 (460.1482)


A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the 1-amino group of 11a-hydroxytetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   
   

RGD (Trifluoroacetate)

RGD (Trifluoroacetate)

C14H23F3N6O8 (460.1529)


RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.

   

TP-060

TP-060

C24H20F4N2O3 (460.141)


Glucosylceramide synthase-IN-1 (T-036) a potent, brain-penetrant and orally active glucosylceramide synthase (GCS) inhibitor with IC50s of 31 nM and 51 nM for human GCS and mouse GCS, respectively. Glucosylceramide synthase-IN-1 can be used for Gaucher's disease research[1].

   

(4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

(4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

C22H24N2O9 (460.1482)


   

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

C27H24O7 (460.1522)


   

(2z,4s,5r,6r,7r,9r)-4,6,7,9-tetrakis(acetyloxy)-5-hydroxy-8-oxododec-2-enoic acid

(2z,4s,5r,6r,7r,9r)-4,6,7,9-tetrakis(acetyloxy)-5-hydroxy-8-oxododec-2-enoic acid

C20H28O12 (460.1581)


   

methyl 6-[(1r)-1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

methyl 6-[(1r)-1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

C28H20N4O3 (460.1535)


   

methyl 6-[1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

methyl 6-[1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

C28H20N4O3 (460.1535)


   

aplopaeonoside

NA

C20H28O12 (460.1581)


{"Ingredient_id": "HBIN016499","Ingredient_name": "aplopaeonoside","Alias": "NA","Ingredient_formula": "C20H28O12","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14343","TCMID_id": "1524","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

asperulosidic acid ethyl ester

NA

C20H28O12 (460.1581)


{"Ingredient_id": "HBIN017141","Ingredient_name": "asperulosidic acid ethyl ester","Alias": "NA","Ingredient_formula": "C20H28O12","Ingredient_Smile": "CCOC(=O)C1=COC(C2C1C(C=C2COC(=O)C)O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "460.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35520","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21580986","DrugBank_id": "NA"}

   

n-[(1s,2r,3r,4r,5r)-3,4-dihydroxy-2-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

n-[(1s,2r,3r,4r,5r)-3,4-dihydroxy-2-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

C22H24N2O9 (460.1482)


   

n-[2,3-dihydroxy-4-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

n-[2,3-dihydroxy-4-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

C22H24N2O9 (460.1482)


   

5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

C27H24O7 (460.1522)


   

1-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone

1-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone

C20H28O12 (460.1581)


   

1-{3-methoxy-4-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]phenyl}ethanone

1-{3-methoxy-4-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]phenyl}ethanone

C20H28O12 (460.1581)


   

n-[3,4-dihydroxy-2-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

n-[3,4-dihydroxy-2-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

C22H24N2O9 (460.1482)


   

4,6,7,9-tetrakis(acetyloxy)-5-hydroxy-8-oxododec-2-enoic acid

4,6,7,9-tetrakis(acetyloxy)-5-hydroxy-8-oxododec-2-enoic acid

C20H28O12 (460.1581)


   

1-(4-methoxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone

1-(4-methoxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone

C20H28O12 (460.1581)


   

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2s,3s,4s)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-methoxyphenyl)ethanone

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2s,3s,4s)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-methoxyphenyl)ethanone

C20H28O12 (460.1581)


   

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-methoxyphenyl)ethanone

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-methoxyphenyl)ethanone

C20H28O12 (460.1581)


   

1-(2-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-4-methoxyphenyl)ethanone

1-(2-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-4-methoxyphenyl)ethanone

C20H28O12 (460.1581)


   

3-(2-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}phenyl)propanoic acid

3-(2-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}phenyl)propanoic acid

C20H28O12 (460.1581)


   

(11r)-5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

(11r)-5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

C27H24O7 (460.1522)


   

1-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone

1-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone

C20H28O12 (460.1581)


   

(1r,17r)-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

(1r,17r)-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

C27H24O7 (460.1522)


   

1-{4-methoxy-2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]phenyl}ethanone

1-{4-methoxy-2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]phenyl}ethanone

C20H28O12 (460.1581)


   

ethyl (1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylate

ethyl (1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylate

C20H28O12 (460.1581)


   

3-(2-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}phenyl)propanoic acid

3-(2-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}phenyl)propanoic acid

C20H28O12 (460.1581)


   

ethyl 7-[(acetyloxy)methyl]-5-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylate

ethyl 7-[(acetyloxy)methyl]-5-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylate

C20H28O12 (460.1581)


   

n-[(1s,2r,3s,4r,5r)-2,3-dihydroxy-4-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

n-[(1s,2r,3s,4r,5r)-2,3-dihydroxy-4-(2-hydroxy-6-methylbenzoyloxy)-5-(c-hydroxycarbonimidoyloxy)cyclohexyl]-3-hydroxybenzenecarboximidic acid

C22H24N2O9 (460.1482)


   

8-(4-hydroxy-3-methoxyphenyl)-6-[(4-hydroxy-3-methoxyphenyl)methyl]-2-methoxy-7-methylnaphthalene-1,4-dione

8-(4-hydroxy-3-methoxyphenyl)-6-[(4-hydroxy-3-methoxyphenyl)methyl]-2-methoxy-7-methylnaphthalene-1,4-dione

C27H24O7 (460.1522)


   

3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

C27H24O7 (460.1522)


   

1-(2-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-4-methoxyphenyl)ethanone

1-(2-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-4-methoxyphenyl)ethanone

C20H28O12 (460.1581)


   

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

C27H24O7 (460.1522)


   

1-(4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-methoxyphenyl)ethanone

1-(4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-methoxyphenyl)ethanone

C20H28O12 (460.1581)


   

(2e)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione

(2e)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione

C22H24N2O9 (460.1482)


   

(3r)-5-{[(2r,3s,4s,5r,6s)-6-(3,4-dimethoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

(3r)-5-{[(2r,3s,4s,5r,6s)-6-(3,4-dimethoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C20H28O12 (460.1581)